Virtus ETF Advisers LLC Merck & Co., Inc. Transaction History

Virtus ETF Advisers LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $823 - $914	-8 Reduced 0.12%	6,766 $696,000
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $141,518 - $154,249	-1,303 Reduced 16.13%	6,774 $781,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $308 - $344	-3 Reduced 0.04%	8,077 $859,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $47,392 - $60,763	542 Added 7.19%	8,080 $896,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $100,675 - $113,097	-1,191 Reduced 13.64%	7,538 $649,000
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $728,784 - $826,112	8,729 New	8,729 $796,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $12,147 - $13,769	-166 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $10,517 - $14,578	166 New	166 $13,000
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $37,859 - $42,719	-488 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $37,127 - $40,469	488 New	488 $41,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.